We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
+27.44%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$10.7M
Cap. Flow
+$855K
Cap. Flow %
0.42%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
PHVS icon
Pharvaris
PHVS
+$4.8M

Top Sells

Rank Stock Value
1
QSI icon
Quantum-Si Incorporated
QSI
+$3.12M
2
LYEL icon
Lyell Immunopharma
LYEL
+$830K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$2.28B
$56.7M 27.86%
3,743,450
+496,524
+15% +$4.8M
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$30.8M 15.17%
485,000
-15,000
-3% -$830K
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$29.3M 14.41%
9,671,643
– –
ACRS icon
4
Aclaris Therapeutics
ACRS
$726M
$29.1M 14.32%
2,808,034
– –
KURA icon
5
Kura Oncology
KURA
$800M
$19.6M 9.62%
1,849,947
– –
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
$19.6M 9.62%
1,787,094
– –
SNDX icon
7
Syndax Pharmaceuticals
SNDX
$1.69B
$18.3M 9%
875,000
– –
QSI icon
8
Quantum-Si Incorporated
QSI
$155M
– –
-1,771,249
Closed -$3.12M

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q2 2023 Portfolio in Review

As of Q2 2023, Foresite Capital Management IV held 8 positions worth $203M, up 5.5% from $193M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management IV's Q2 2023 filing shows 1 increased, 1 reduced and 1 closed positions. The largest sale was Quantum-Si Incorporated, an estimated $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV added most to Pharvaris in Q2 2023, an estimated $4.8M increase.
  • Foresite Capital Management IV's biggest Q2 2023 reduction was Lyell Immunopharma, cutting an estimated $830K.
  • Foresite Capital Management IV fully exited Quantum-Si Incorporated in Q2 2023, selling an estimated $3.12M.
  • Foresite Capital Management IV's ten largest holdings make up 100% of its $203M portfolio in Q2 2023.
  • Foresite Capital Management IV opened 0 new positions and closed 1 in Q2 2023.
  • Foresite Capital Management IV's portfolio value rose 5.5% quarter-over-quarter to $203M.

Based on Foresite Capital Management IV's 13F filing for Q2 2023, filed 11 Aug 2023.